• Haidee A Gonzalez, Sally Myers, Emma Whitehead, Alisson Pattinson, Katie Stamp, Jack Turnbull, Rebecca Fory, Bethia Featherstone, Amy Wilkinson, Jessica Lisle, Greg Haire, Eileen Henderson, and Shaji Sebastia.
• Hull University Teaching Hospitals NHS Trust, Hull, UK.
• Clin Med (Lond). 2020 Sep 1; 20 (5): e183e188e183-e188.

IntroductionHealthcare organisations have had to make adaptations to reduce the impact of the Coronavirus 2019 (COVID-19) pandemic. This has necessitated urgent reconfiguration within inflammatory bowel disease (IBD) services to ensure safety of patients and staff and seamless continuity of care provision.AimTo describe the adaptations made by a large inflammatory bowel disease service, caring for over 3,500 IBD patients, in response to the COVID-19 pandemic.MethodsA diary record of responses to the pandemic were logged, and meeting minutes were reviewed. Data were recorded from IBD advice lines, multidisciplinary team (MDT) meeting minutes, infusion unit attendances, and electronic referral systems for the 8-week period from 9 March 2020 until 2 May 2020. Descriptive analysis was performed.ResultsThe IBD service at Hull University Teaching Hospitals NHS Trust (IBD Hull) instituted rapid structural and functional changes to the service. Outpatient services were suspended and substituted by virtual consultations, and inpatient services were reduced and moved to ambulatory care where possible. The delivery of biologic and immunomodulatory therapies was significantly modified to ensure patient and staff safety. There was a substantial increase in IBD advice line calls.ConclusionThe rapidly evolving COVID-19 pandemic required a prompt response, regular reassessment and planning, and continues to do so. We share our experience in of the successful adaptations made to our IBD service.© Royal College of Physicians 2020. All rights reserved.

34 keywords...

hide…